Study Group: Physicians who Treat Patients with Acute Coronary Syndromes (US)(?)
Council Members in this Study Group: 90
Request a survey with this Study Group
Leading Experts in this Study Group
Professor of Medicine
Finch University of Health Science-Chicago Medical School
Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is a Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School, Illinois. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Dr. Arora is also Chief of Cardiology at the North...
Michael Davidson, MD, FACCDirector, Preventive Cardiology
The University of Chicago
Michael Davidson, MD, FACC, is Executive Medical Director at Radiant Research, Director of Preventive Cardiology and Clinical Professor of Medicine at the University of Chicago Pritzker School of Medicine. In addition, he is Founder, President, and Chief Executive Officer of the Chicago Center for Clinical...
Associate Professor
Feinberg School of Medicine, Northwestern University
Michael Kim, MD, is an Associate Professor at Feinberg School of Medicine, Northwestern University, Illinois. He has served as a Cardiac Electrophysiologist at Health Partners and Regions Hospital in Minnesota and also as an Associate Professor at the University of Minnesota. Dr. Kim has expertise in...
Samuel Butman, MDInterventional Cardiologist
Verde Valley Heart LLC
Samuel Butman, MD, is an Interventional Cardiologist at Verde Valley Medical Center. Dr. Butman is also a Clinical Associate Professor of Medicine at University Medical Center in Tucson, Arizona. He has also served as the Director of Cardiology Interventional Fellows Program and Director of Cardiac...
Director of Cardiovascular Research
Sinai Hospital of Baltimore Inc
Paul Gurbel, MD, is Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital of Baltimore. Dr. Gurbel has authored over 100 peer-reviewed papers related primarily to coronary thrombosis and interventional cardiology. His particular expertise is in translational platelet...
Charles Glueck, MDMedical Research Director of Cholesterol Center
Jewish Hospital
Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...
Vice-Chairman of Cardiovascular Medicine
OSF Saint Francis Medical Center
Dale Mueller, MD, is a Cardiovascular and Thoracic Surgeon at Heartcare Midwest and Vice-Chairman of the Department of Cardiovascular Medicine and Surgery at OSF Saint Francis Medical Center in Illinois. He has expertise in cardiac surgery including minimally-invasive coronary bypass, valve repair and...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
The JUPITER trial showed that people with what is regarded as normal ('bad') cholesterol and elevated C-reactive protein benefit more from the choleterol lowering drug rosuvastatin (Crestor, Astra-Zeneca) than from placebo. The first question is: is this true only for this particular type of statin...
The Endeavour stent appears to have a higher restenosis rate than currently marketed Drug Eluting Stents without the improved safety profile claimed by the company. This finding is at odds with the companies marketing message to cardiologists. These studies, along with the introduction of...
This plan to start a large trial to determine the optimal antiplatelet therapy. after [drug-eluting] stent implantation makes sense both scientifically and economically for the involved stent companies (Johnson & Johnson, Boston Scientific, Medtronic and Abbott). Sanofi-Aventis and Bristol Myers...
The growth of the big pharma companies in the past 20-30 years has to do with the fact that the medical community was willing to accept large trials (some with surrogate endpoints) as proof that a new treatment is good and that it can replace the old one. Since the problems with Troglitazone, Cerivastatin,...
The anemia drug erythropoietin and its congeners have been used extensively in patients with renal failure and in patients with cancer to boost the red cell count. However, erythropoietin also helps reduce programmed cellular death and is involved in the growth of new vessels. Because of these features...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Other Freestanding Healthcare Facility
- Government/Military Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Department Chair
- Physician - Division Head
- Owner
- Medical Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms